Today was the first day of a two-day conference on "Injunctions and Flexibility in Patent Law - Civil Law and Common Law Perspectives" organized and hosted by the l
The Federal Circuit recently vacated a district court decision which found a patent for the antipsychotic drug “Saphris,” belonging to Forest Laboratories (Forest), valid as nonobvious, but not infringed by ANDA filers Alembic Pharmaceuticals Ltd.
Amster, Rothstein & Ebenstein LLP is looking for a Patent Prosecution junior associate in the mechanical or technical arts with 2 - 5 years experience. The position is located in New York City.
Apart from PR, the mid-March verdict that a San Diego jury rendered in Qualcomm's favor over three patents isn't overly useful to Qualcomm in its own rig
By Donald Zuhn –- USPTO Implements New System for Ordering Certified Copies of Documents In a notice posted on the U.S.
Later today, the Senate Subcommittee on Intellectual Property will hold a hearing titled Trailblazers and Lost Einsteins: Women Inventors and the Future of American Innovation—a topic that also was considered last Wednesday by the House Committee
Inequitable conduct remains the most powerful defense to patent infringement. In contrast to other defenses to patent infringement that require a claim-by-claim analysis, the defense of inequitable conduct is global.
Yesterday the Free Democratic Party (FDP) group in the German Bundestag (federal parliament) made the decision to bring a motion calling on the German government to prevent the adoption of the EU copyright reform bill in its current form by the EU
In ChargePoint Inc. v.
On March 8, Foster Pepper filed a petition for certiorari with the Supreme Court, case number 18-1199, challenging the Federal Circuit’s emerging “physical realm” test as part of its Alice/Section 101 analysis.